Azo-Truxazole Drug Interactions
Currently displaying 100 drugs known to have a moderate interaction with Azo-Truxazole (phenazopyridine / sulfisoxazole).
Moderate interactions with Azo-Truxazole (phenazopyridine / sulfisoxazole)
Note: Showing generic names only.
A
- acetohexamide
- aminolevulinic acid topical
- asparaginase erwinia chrysanthemi
- asparaginase escherichia coli
B
- balsalazide
- bedaquiline
- benoxinate ophthalmic
- benzocaine topical
- bifidobacterium infantis
- black cohosh
- brentuximab
- bupivacaine
- bupivacaine liposome
C
- calaspargase pegol
- cannabidiol
- chloramphenicol ophthalmic
- chloramphenicol otic
- chloroprocaine
- chloroprocaine ophthalmic
- chlorpropamide
- clofarabine
- cocaine nasal
- cocaine topical
D
E
F
G
I
- idelalisib
- indium oxyquinoline in-111
- insulin
- insulin aspart
- insulin aspart protamine
- insulin degludec
- insulin detemir
- insulin glargine
- insulin glulisine
- insulin inhalation, rapid acting
- insulin isophane
- insulin lispro
- insulin lispro protamine
- insulin regular
- insulin zinc
- insulin zinc extended
- interferon beta-1a
- interferon beta-1b
- isoniazid
L
- lactobacillus acidophilus
- lactobacillus reuteri
- lactobacillus rhamnosus
- lactobacillus rhamnosus gg
- levobupivacaine
- lidocaine
- lidocaine ophthalmic
- lidocaine otic
- lidocaine topical
M
N
P
R
S
T
V
Azo-Truxazole disease interactions
There are 12 disease interactions with Azo-Truxazole (phenazopyridine / sulfisoxazole) which include:
- colitis
- G-6-PD deficiency
- hepatitis
- renal dysfunction
- hematologic toxicity
- hypersensitivity reactions
- liver disease
- porphyria
- renal dysfunction
- crystalluria
- hemodialysis
- urinary obstruction
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.